» Articles » PMID: 10358063

Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes. A Hit and Run Phenomenon

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1999 Jun 8
PMID 10358063
Citations 177
Authors
Affiliations
Soon will be listed here.
Abstract

The pathological correlates of dementia due to human immunodeficiency virus (HIV) infection are glial cell activation and cytokine dysregulation. These findings occur in the setting of small numbers of productively infected cells within the brain. We determined whether exposure of susceptible cells to Tat protein of HIV could result in the production of select proinflammatory cytokines. In a dose-responsive manner, Tat induced interleukin (IL)-1beta production in monocytic cells, while astrocytic cells showed an increase in mRNA for IL-1beta, but had a translation block for IL-1beta protein production. Conversely, IL-6 protein and mRNA productions were strongly induced in astrocytic cells and minimally in monocytic cells. IL-1beta and IL-6 production were independent of tumor necrosis factor-alpha production. An exposure to Tat for a few minutes was sufficient for sustained releases of cytokines for several hours. This prolonged cytokine production is likely maintained by a positive feed back loop of Tat-induced nuclear factor kappaB activation and cytokine production that is independent of extracellular calcium. Thus a transient exposure may be sufficient to initiate a cascade of events resulting in cerebral dysfunction and a "hit and run" approach may be in effect. Hence cross-sectional measurement of viral load in the brain may not be a useful indicator of the role of viral products in the neuropathogenesis of HIV dementia.

Citing Articles

Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder.

Ewens A, Pilski A, Hastings S, Krook-Magnuson C, Graves S, Krook-Magnuson E J Pharmacol Exp Ther. 2024; 391(1):104-118.

PMID: 39060163 PMC: 11413936. DOI: 10.1124/jpet.124.002272.


Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice.

Yadav-Samudrala B, Dodson H, Ramineni S, Kim E, Poklis J, Lu D PLoS One. 2024; 19(6):e0305868.

PMID: 38913661 PMC: 11195999. DOI: 10.1371/journal.pone.0305868.


Transactivator of Transcription (Tat)-Induced Neuroinflammation as a Key Pathway in Neuronal Dysfunction: A Scoping Review.

Muvenda T, Williams A, Williams M Mol Neurobiol. 2024; 61(11):9320-9346.

PMID: 38627350 PMC: 11496333. DOI: 10.1007/s12035-024-04173-w.


The cell biology of HIV-1 latency and rebound.

Mbonye U, Karn J Retrovirology. 2024; 21(1):6.

PMID: 38580979 PMC: 10996279. DOI: 10.1186/s12977-024-00639-w.


Acute Administration of HIV-1 Tat Protein Drives Glutamatergic Alterations in a Rodent Model of HIV-Associated Neurocognitive Disorders.

Duffy B, King K, Nepal B, Nonnemacher M, Kortagere S Mol Neurobiol. 2024; 61(10):8467-8480.

PMID: 38514527 PMC: 11415472. DOI: 10.1007/s12035-024-04113-8.